The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Bristol-Myers Squibb; Novartis
ENESTop 192-week results: Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after stopping second-line (2L) nilotinib (NIL).
 
Timothy P. Hughes
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Novartis (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Carla Boquimpani
No Relationships to Disclose
 
Naoto Takahashi
Honoraria - Novartis; Otsuka; Pfizer
Consulting or Advisory Role - Novartis; Otsuka
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Otsuka; Pfizer
Research Funding - Novartis (Inst); Otsuka (Inst); Pfizer (Inst)
 
Noam Benyamini
No Relationships to Disclose
 
Nelma Cristina D. Clementino
No Relationships to Disclose
 
Vasily Shuvaev
Consulting or Advisory Role - Fusion Antibodies; Novartis
Speakers' Bureau - Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Jeffrey Howard Lipton
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
 
Anna G. Turkina
No Relationships to Disclose
 
Raquel De Paz Arias
No Relationships to Disclose
 
Beatriz Moiraghi
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pinth Farma; Takeda
 
Franck E. Nicolini
Honoraria - Bristol-Myers Squibb; Incyte; Novartis
Consulting or Advisory Role - Incyte
Speakers' Bureau - Bristol-Myers Squibb; Incyte
Travel, Accommodations, Expenses - Incyte
 
Jolanta Dengler
No Relationships to Disclose
 
Tomasz Sacha
Honoraria - Acraf; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Acraf; Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Acraf; Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - Acraf; Bristol-Myers Squibb; Novartis; Pfizer
 
Dong-Wook Kim
Honoraria - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Otsuka
Consulting or Advisory Role - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Otsuka; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Otsuka; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); IL-Yang Pharm (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
 
Rafik Fellague-Chebra
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis (Inst)
Other Relationship - Novartis
 
Sandip Acharya
Employment - Novartis
 
Catherine Bouard
Employment - Novartis
 
Francois-Xavier Mahon
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Celgene